Pharmacokinetics of Zanamivir After Intravenous, Oral, Inhaled or Intranasal Administration to Healthy Volunteers

Overview of attention for article published in Clinical Pharmacokinetics, November 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

policy: 1 policy source

patent: 3 patents

Citations

dimensions_citation: 190 Dimensions

Readers on

mendeley: 69 Mendeley

Summary Policy documents Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

De novo designed hemagglutinin binding proteins

Grant US-10766929-B2

United States of America

ENHANCED ANTI-INFLUENZA AGENTS CONJUGATED WITH ANTI-INFLAMMATORY ACTIVITY

Application EP-3524272-A1

European Patent Office

ENHANCED ANTI-INFLUENZA AGENTS CONJUGATED WITH ANTI-INFLAMMATORY ACTIVITY

Application WO-2013155375-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.